UCONN

HEALTH

Photo of Nitya G. Chakraborty, Ph.D.

Nitya G. Chakraborty, Ph.D.

Associate Professor, Department of Medicine
Academic Office Location:
Medicine
UConn Health
263 Farmington Avenue
Farmington, CT 06030-1628
Phone: 860-679-1446
Fax: 860-679-1159
Education
DegreeInstitutionMajor
B.Sc.University of Calcutta, Chemistry, Physics, Math
M.S.Institute of ChemistsChemistry/ Biochemistry
Ph.D.Patna University, Chemistry

Post-Graduate Training
TrainingInstitutionSpecialty
PostdoctoralUniversity of Connecticut Health CenterPostdoctoral Fellow, Cellular &Molecular Immunology
PostdoctoralUniversity of Connecticut Health CenterPostdoctoral Research Associate, Cellular & Molecular Immunology

Awards
Name of Award/HonorAwarding Organization
First Prize for Research Paper Annual Meeting of American College of Surgeons
Elected Fellow Institution of Chemists, India
Award for Research Paper on Cancer Immunology Annual Meeting of American College of Surgeons
Name & DescriptionCategoryRoleTypeScopeStart YearEnd Year
Journal Clinical and Developmental ImmunologyEditorial BoardMemberExternalNational2011
Cancer LetterProfessional/Scientific JournalReviewerExternalNational2008
Journal PLOne ScienceProfessional/Scientific JournalReviewerExternalInternational2008
Philip Morris External Research ProgramProfessional/Scientific OrganizationReviewerExternalNational2007
Journal of Cancer Immunol ImmunotherapyProfessional/Scientific JournalReviewerExternalNational2007
Journal Experimental DermatologyProfessional/Scientific JournalReviewerExternalNational2007
ImmunologyProfessional/Scientific JournalReviewerExternalNational2006
Journal of Leukemia LymphomaProfessional/Scientific JournalReviewerExternalNational2005
Journal of Clinical Cancer ResearchProfessional/Scientific JournalReviewerExternalNational2004
American Association for Cancer ResearchProfessional/Scientific OrganizationMemberExternalNational2002
Journal of Institute of Post Graduate MedicineProfessional/Scientific JournalReviewerExternalNational2002

Journal Articles

Book Chapters

  • Synthetic Peptide Pulsed Autologous Cultured Antigen Pntigen Presenting Cells as a Melanoma Vaccine
    Mukherji, B., Chakraborty, N.G., Hu, X., and Sakamoto, T. Immunology of Human Melanoma 201-208

Abstracts

  • Study of Suppressor Cells in Cell Culture System
    Chakraborty, N.G., Sporn, J.R., Ergin, M.T., and Mukherji, B. Proc. of Australians Society of Oncologists

Conference Papers

Notes

Reviews

Title or AbstractTypeSponsor/EventDate/YearLocation
Comprehensive Analyses of the T Cell-Mediated Adaptive Immune Function in the Elderly Melanoma PatientsTalkAACR2011Orlanda, Florida
MHC –I TCR Engineered CD4+ Cells as Multi Functional for Immunotherapy of CancerTalkAACR2010Washington, DC
MHC Class I Restricted Melanoma Epitope Specific TCR Engineered Human CD4 T Cells Provide Effector Function, Proliferate upon Cognate Stimulation, Amply CD8+ CTL Generation and Mitigate Inducible T Reg Cell Activities in Human Melanoma, In VitroTalkFederation of Clinical Immunology2009San Francisco, California
Functional Differences Between Induced T Reg Cells from Tumor Antigen Specific CTL Induction and Influenza Matrix Antigen Specific CTL Induction CulturesTalkAACR2009Denver, Colorado
To Block the T Regulatory Cell Response for the Success for Cytotoxic T Lymphocyte Mediated Immunotherapy for CancerLectureInstitute of Life Science2009Bhubaneswar, India
Lack of T Reg Cell Functions and Melanoma Tumor Antigen Specific Responses in Some Elderly PatientsTalkAACR2008
MHC Class-I Restricted Tumor Epitope Specific TCR Engineered CD4+ T Cells Function as Helper and Cytolytic Effector Cells in Anti Tumor ImmunityTalkInternational Society for Biological Therapy for Cancer2007Boston, Massachusetts
Th1 Conditions are Necessary for Longer Lasting Tumor Specific CTL Activity: Cychlophosphamide/ Fluderabine Could Play Important Role by Blocking T RegsTalkAnnual Meeting AACR2007Los Angeles, California
Obstacles to Overcome for the CTL Based Immunotherapy for CancerLectureChittaranjan National Cancer Institute2006Kolkata, India
Regulatory T Cell Response and CTL- Based Immunotherapy for MelanomaLectureKing Edward Medical College and Hospital2006Mumbai, India
CTL-based Immunotherapy for CancerLectureIndian Institute of Technology2006Kharagpur, India
Activation Induced Cell Death in Non-Self/Dangerous Influenza Epitope Specific Human Cytolytic T Lymphocytes with Memory Phenotype is Inhibited by JNK Inhibitor, SP600125TalkAmerican Association of Immunologists2006Boston, Massachusetts
Effect of Regulatory T Cells on Activation and Expansion of Tumor Epitope Specific CTL In VitroTalkAACR Annual Meeting2005
Rescuing Tumor Antigen Specific Cytotoxic T Lymphocytes (CTLs) from Activation Induced Cell DeathTalkInternational Immunology Congress2004Montreal, Canada
Regulation of Melanoma Epitope Specific Cytotoxic T Cell Response by Dendritic CellsTalkAnnual Meeting of AACR2003Washington, DC
Regulatory T Cell Response and Tumor Antigen Plus Dendritic Cell Based Vaccine in Human CancerTalkInternational Conference in Emerging Trend in Cancer Research2002New Delhi
Recent Development for Immunotherapy of CancerTalkJawharlal Neheru University2002New Delhi, India
Rapid Restoration of Restoration of Immune Function After Autologous Stem Cell Transplantation by Adoptive Transfer of Mature Donor.TalkAmerican Society of Haematologists1999New Orleans, Louisiana
Cancer Vaccine DevelopmentLectureAmsterdam Medical Center1999Netherlands, Amsterdam
Role of Regulatory T Lymphocytes in Cancer Vaccine DevelopmentPlenary LectureInternational Immunology Congress1998Calcutta
Th2 Type CD4+ T Cell Generation Following Repetitive Stimulation with Peptide Loaded Autologous Antigen Presenting Cells In Vitro; Implication in Cancer VaccineTalkInternational Immunology Congress1998
Induction of Tumor Associated Antigen Specific CTL Response in Melanoma PatientsLectureInternational Immunology Congress1998Calcutta, India
Role of Regulatory T Lymphocytes in CancerTalkAmerican Cancer Society Ex cali1998
Melanoma Cell Lysate Loaded Autologous Antigen Presenting Cells (APC) as a Vaccine in MelanomaTalkAACR1997San Diego, California
Induction of Specific CTL Response in Melanoma Patients In Vivo with Synthetic Peptide and Antigen Presenting Cell-Based VaccineTalkNew England Cancer Society1995Boston, Massachusetts
Immunization of Melanoma Patients with Synthetic MAGE-1 Peptide Pulsed Autologous MacrophagesTalkInternational Cancer Meeting1995Paris, France
Autologous Melanoma Reactive T Cell Clone that Suppress Cytotoxic T Cell ResponseTalkAmerican Assoc. of Immunologists1990New Orleans, Louisiana
In Vitro Correlates of Immunizing Efficacy of Dye Treated Tumor CellsTalk73rd Indian Science Congress Assoc.1986New Delhi
Induction of Anti Tumor Resistance by Soluble Tumor Antigens from Modified Tumor CellsTalkIndian Science Congress Assoc, Med. & Vet. sec.1985
Induction of Transplantation Immunity Against Different Tumors in Mice Model by Dye Treated Tumor CellsTalk71st Indian Science Congress Assoc. Med. & Vet. Sec.1984
Effects of Lectins in the Reactivity of Native and Chemically Modified Tumor CellsTalkIndian Science Congress Assoc. Med.& Vet. sec.1983
Presence of FC-Receptor Bearing Tumor Cells in a Murine Transplantable TumorTalkInternational Conference in Current Trends in Cancer Research1982
Study of Cytotoxicity and Phagocytosis by Tumor Associated Macrophages in Relation to Progression of TumorTalkInternational Conference in Current Trends in Cancer Research1982
Bose Enhancement of Immunogenicity of Tumor Cell by Cell Surface Modification with Acridine DyesTalkIndian Science Congress1980